Raphael Pharmaceutical (RAPH) Invested Capital (2020 - 2025)
Raphael Pharmaceutical (RAPH) reported Invested Capital of $34000.0 for Q4 2025, down 17.07% on a YoY basis from $41000.0 in Q4 2024, and down 17.07% sequentially from $41000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Invested Capital (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 5 years of Invested Capital data on file, last reported at $34000.0 in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital fell 17.07% year-over-year to $34000.0; the trailing twelve-month figure through Dec 2025 stood at $157000.0 (up 282.93% YoY), and the FY2025 full-year result was $34000.0, down 17.07% from the prior year.
- Invested Capital fell to $34000.0 in Q4 2025, from $41000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $41000.0 in Q4 2024 to a low of $1000.0 in Q1 2022.
- A 4-year average of $26444.4 and a median of $34000.0 in 2025 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital soared 144.44% in 2021 and sank 86.36% in 2022, its largest moves.
- Tracing RAPH's Invested Capital over 4 years: stood at $22000.0 in 2021, then slumped by 86.36% to $3000.0 in 2022, then jumped by 1266.67% to $41000.0 in 2024, then fell by 17.07% to $34000.0 in 2025.
- Business Quant data shows RAPH's Invested Capital at $34000.0 in Q4 2025, $41000.0 in Q3 2025, and $41000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2020 | 9,000.00 |